- Fee assured
- Verified account
- Gynaecological oncology
Miss Kavita Singh is an accredited Gynaecologist and Gynaecological cancer surgeon with over 25 years experience. Her expertise extends to management of all types of gynaecological cancers which include ovarian, cervical and uterine cancers. She is well known in UK for her advanced surgical skills in all types of complex pelvic surgery. Her strengths are management of advanced ovarian cancers, recurrent pelvic cancers and exenterative surgery.
She is a skilled laparoscopic surgeon and has introduced total laparoscopic radical hysterectomy for management of cervical cancer in Midlands in 2008. Her surgical interests also include fertility preserving surgery like trachelectomy for cervical cancer, which she has modified and improved the techniques from vaginal to abdominal and now laparoscopic approach.
Miss Singh provides expert management for endometriosis, abnormal vaginal bleeding, smear abnormalities/colposcopy, hormone replacement and screening advice for gynaecological cancers.
Miss Singh has acquired her clinical training by having worked in several centers of clinical excellence in India, UK, USA, France and Ethiopia. She began her medical training in India and continued in England. She acquired her general gynaecology training with expertise in pelvic floor and vulval disorders at the Royal Free Hospital, London under the guidance of Professor Allan Maclean & Wendy Reid. She has acquired specialized training in fistula repair surgery at the Fistula Hospital in Addis Ababa, Ethiopia. She has also worked on research projects in the Surgical Planning Lab in the Brigham and Women’s hospital in Boston, USA.
She obtained her gynaecological oncology training in Birmingham and France. She acquired her subspecialist training under the tutelage of well known Mr “Charlie” K. K. Chan. She advanced her laparoscopic and open radical surgical skills further, by working with Professor Denise Querleu and Gwen Ferron at the renowned Claudius Regaud Institute, Toulouse.
She has been a Consultant Gynaecological Oncologist at the Pan-Birmingham Gynaecological Cancer Centre since 2005.
She is regularly invited to teach and to perform surgery abroad. She is the programme director for subspecialty training in Gynaecological Oncology in Birmingham. She has taught and continues to teach advanced laparoscopic surgical techniques in India and at the European Surgical Institute in Hamburg, Germany.
She is actively involved in research, publishes scientific papers regularly and is a reviewer for national and international Gynaecology and Gynaecological Oncology journals.
She is a Fellow of the Royal College of Obstetricians and Gynaecologists and member of the British and International Gynaecological Cancer Society (BGCS & IGCS).
She is polite, thoughtful and modest in her temperament and passionate about the quality of her surgical performance.
Areas of interest
Women' cancers including:
Ovarian cancer; Uterine/womb cancer; Cervical/cervix cancer; Vulval & Vaginal cancer;
Cancer risk assessment;
Fertility preserving surgery for cancer;
Ovarian cysts, fibroids, endometriosis, pelvic pain;
Laparoscopic procedures ('keyhole surgery');
Day case laparoscopic hysterectomy;
Postmenopausal and abnormal vaginal bleeding;
Menopause, hormone replacement;
Vulval and vaginal diseases
Anaesthetists worked with
Current NHS consultant posts held
Pan-Birmingham Gynaecology Cancer Centre,
City Hospital, SWBH NHS Trust
(Additional) Languages spoken
- Hindi - Native or bilingual
1. Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention. Pounds R, Phillips A, Kehoe S, Nevin J, Sundar S, Elattar A, Teo HG, Singh K, Balega J.Eur J Obstet Gynecol Reprod Biol. 2018 Jul;226:47-53.
2. Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer.Phillips A, Sundar S, Singh K, Nevin J, Elattar A, Kehoe S, Balega J.Eur J Surg Oncol. 2018 Jun;44(6):760-765.
3. Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer. Phillips A, Singh K, Pounds R, Sundar S, Kehoe S, Nevin J, Elattar A, Balega J. J Obstet Gynaecol. 2017 Nov;37(8):1070-1075.
4. Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.Phillips A, Balega J, Nevin J, Singh K, Elattar A, Kehoe S, Sundar S. Gynecol Oncol. 2017 Apr 12
5. Neuroendocrine Carcinoma of the Cervix: Review of a Series of Cases and Correlation With Outcome. Ganesan R, Hirschowitz L, Dawson P, Askew S, Pearmain P, Jones PW, Singh K, Chan KK, Moss EL.Int J Surg Pathol. 2016 Sep;24(6)
6. The Effect of Country of Birth on the Pattern of Disease and Survival From Cervical Cancer. Moss E, Askew S, Cheung S, Dawson P, Singh K, Redman CW, Pearmain P.J Low Genit Tract Dis. 2016 Jan;20(1):38-43.
7. Outcomes Following Interval Debulking Surgery in Primary Peritoneal Carcinoma.
8. Connolly CF1, Yahya S2, Chan KK3, Singh K3, Sundar S4, Anwar SM5, Fernando I5 Anticancer Res. 2016 Jan;36(1):255-9
9. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma? Moss EL, Evans T, Pearmain P, Askew S, Singh K, Chan KK, Ganesan R, Hirschowitz L. Int J Gynecol Cancer. 2015 Sep;25(7):1201-7.
10. Surgical and oncological outcome of total laparoscopic radical hysterectomy in obese women with early-stage cervical cancer. Moss EL, Balega J, Chan KK, Singh K. Int J Gynecol Cancer. 2012 Jan;22(1):101-6.
11. Is laparoscopic sterilisation an anachronism?El Moss, L Hirschowitz, K Singh BJOG An International Journal of Obstetrics & Gynaecology 11/2012; 119(12):1545-6.
Courses offered to GPs
1. Changes in radicality of surgery in cervical & Endometrial cancer - AOGD conference 25/11/18 , New Delhi
2. Meet the expert for cervical cancer ( Q&A for patients)- organized by Jo’S charity Trust May 17, Birmingham
3. Salvage surgery in advanced stage cervical cancer –British Gynaecology Cancer Society meeting May 2016, Birmingham
4. Surgical technique for doing splenectomy- surgical study day, May 2016, Birmingham
5. Tips & Tricks in Ovarian cancer surgery – AGOICON Feb2017 Del
- FRCOG Royal College of Obstetricians & Gynaecologists 2011
- MRCOG Royal College of Obstetricians & Gynaecologists 1995
- MD Delhi University 1990
- MBBS Lady Hardinge Medical School, New Delhi, India 1987
- Subspecialty In Gynaecological Oncology Birmingham cancer Centre 2003
Reference number 4284639
Professional bodies (positions held - last 3 yrs)
- Subspecialty Training Director Pan-Birmingham Gynaecology Cancer centre 2012
Details of entry to specialist register
- CCT in Gynaecology & Gynaecological Oncology, 2005
Affiliations / memberships
- 1 Damson Parkway SOLIHULL B91 2PP
- 16:00 - 18:00
- 07951 096015
- 22 Somerset Road Edgbaston BIRMINGHAM B15 2QQ
- 16:00 - 18:30
- 07951 096015
- Priory Road Edgbaston BIRMINGHAM B5 7UG
- 17:00 - 20:00
- 07951 096015
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details